BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33749163)

  • 21. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
    Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score.
    Tekin N; Omidvar N; Morris TP; Conget P; Bruna F; Timar B; Gagyi E; Basak R; Naik O; Auewarakul C; Sritana N; Levy D; Cerci JJ; Bydlowski SP; Pereira J; Dimamay MP; Natividad F; Chung JK; Belder N; Kuzu I; Paez D; Dondi M; Carr R; Ozdag H; Padua RA
    Oncotarget; 2016 Dec; 7(50):83319-83329. PubMed ID: 27825111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a prognostic metabolic gene signature in diffuse large B-cell lymphoma.
    Wang H; Shao R; Liu W; Tang H; Lu Y
    J Cell Mol Med; 2021 Jul; 25(14):7066-7077. PubMed ID: 34128320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling.
    Mosquera Orgueira A; Díaz Arias JÁ; Cid López M; Peleteiro Raíndo A; Antelo Rodríguez B; Aliste Santos C; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; González Pérez MS; Pérez Encinas MM; Fraga Rodríguez MF; Bello López JL
    BMC Cancer; 2020 Oct; 20(1):1017. PubMed ID: 33087075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
    He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
    J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study.
    Wang M; Ma S; Shi W; Zhang Y; Luo S; Hu Y
    Cancer Med; 2021 May; 10(10):3474-3485. PubMed ID: 33931950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma.
    Wang WL; Yang C; Han XL; Wang R; Huang Y; Zi YM; Li JD
    Med Oncol; 2014 Apr; 31(4):919. PubMed ID: 24659264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of survival of diffuse large B-cell lymphoma patients via the expression of three inflammatory genes.
    Zhao S; Bai N; Cui J; Xiang R; Li N
    Cancer Med; 2016 Aug; 5(8):1950-61. PubMed ID: 27394196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma.
    Mu S; Shi D; Ai L; Fan F; Peng F; Sun C; Hu Y
    Front Immunol; 2021; 12():732006. PubMed ID: 34745101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
    Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
    Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
    Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
    Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
    Xing Q; Liu S; Luan J; Wang Y; Ma L
    Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Meng B; Zhang H
    Hematol Oncol; 2019 Oct; 37(4):360-367. PubMed ID: 31359442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
    Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
    BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
    Troppan KT; Melchardt T; Deutsch A; Schlick K; Stojakovic T; Bullock MD; Reitz D; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Egle A; Pichler M
    Eur J Haematol; 2015 Dec; 95(6):538-44. PubMed ID: 25677782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma.
    Wu Z; Guan Q; Han X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Wang X; Zhang H
    Aging (Albany NY); 2021 Oct; 13(19):22947-22962. PubMed ID: 34610582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
    Montes-Moreno S; Martinez N; Sanchez-Espiridión B; Díaz Uriarte R; Rodriguez ME; Saez A; Montalbán C; Gomez G; Pisano DG; García JF; Conde E; Gonzalez-Barca E; Lopez A; Mollejo M; Grande C; Martinez MA; Dunphy C; Hsi ED; Rocque GB; Chang J; Go RS; Visco C; Xu-Monette Z; Young KH; Piris MA
    Blood; 2011 Jul; 118(4):1034-40. PubMed ID: 21633089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
    Li J; Fu R; Yang L; Tu W
    Int J Clin Exp Pathol; 2015; 8(11):15019-24. PubMed ID: 26823838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.